Atrion Corporation (ATRI) stock remained unchanged at $459.92 a share on NASDAQ. The stock opened at $459.75, fluctuating between $459.75 to $459.92 during the session.
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Employees | 712 |
Beta | 0.688 |
Sales or Revenue | $169.33M |
5Y Sales Change% | 0.169% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Instruments & Supplies |
Atrion Corporation (NASDAQ: ATRI) stock price is $459.92 in the last trading session. During the trading session, ATRI stock reached the peak price of $459.92 while $459.75 was the lowest point it dropped to. The percentage change in ATRI stock occurred in the recent session was 0% while the dollar amount for the price change in ATRI stock was $0.00.
The NASDAQ listed ATRI is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Atrion Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Cindy Ferguson
Vice President, Chief Financial Officer, Sec. & Treasurer
Mr. David A. Battat
Pres & Chief Executive Officer
Mr. Jeffery Strickland
Chief Financial Officer, Vice President, Treasurer & Sec.
Mr. Emile A. Battat
Executive Chairman
ATRI's closing price is 67.26% higher than its 52-week low of $274.98 where as its distance from 52-week high of $503.24 is -8.61%.
Number of ATRI employees currently stands at 712.
Official Website of ATRI is: https://www.atrioncorp.com
ATRI could be contacted at phone 972 390 9800 and can also be accessed through its website. ATRI operates from One Allentown Parkway, Allen, TX 75002-4211, United States.
ATRI stock volume for the day was 29.52K shares. The average number of ATRI shares traded daily for last 3 months was 21.34K.
The market value of ATRI currently stands at $809.44M with its latest stock price at $459.92 and 1.76M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com